OLD National Bancorp IN Has $1.31 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

OLD National Bancorp IN decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 17.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,139 shares of the pharmacy operator’s stock after selling 10,681 shares during the period. OLD National Bancorp IN’s holdings in Walgreens Boots Alliance were worth $1,309,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Walgreens Boots Alliance by 14.5% during the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares during the period. Invesco Ltd. raised its stake in shares of Walgreens Boots Alliance by 21.5% in the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock valued at $378,668,000 after acquiring an additional 3,013,807 shares during the last quarter. Morgan Stanley raised its stake in shares of Walgreens Boots Alliance by 15.8% in the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after acquiring an additional 1,720,228 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Walgreens Boots Alliance by 3.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 5,905,998 shares of the pharmacy operator’s stock valued at $131,349,000 after acquiring an additional 212,161 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of Walgreens Boots Alliance by 12.4% in the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,077,336 shares of the pharmacy operator’s stock valued at $80,349,000 after acquiring an additional 339,143 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Insider Transactions at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 13,456 shares of company stock valued at $270,423. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Trading Down 0.9 %

WBA opened at $18.05 on Wednesday. The stock has a market capitalization of $15.57 billion, a P/E ratio of -2.58, a P/E/G ratio of 1.13 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a 12 month low of $17.51 and a 12 month high of $35.54. The firm’s fifty day simple moving average is $20.26 and its 200 day simple moving average is $21.86. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same quarter in the prior year, the firm posted $1.16 EPS. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on WBA. Barclays began coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 target price for the company. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. TD Cowen cut their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. Deutsche Bank Aktiengesellschaft cut their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Finally, UBS Group lowered their price target on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Wednesday, April 3rd. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $24.36.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.